Matica Bio, a global viral vector CDMO for cell&gene therapy
Matica Biotechnology is a contract development and manufacturing organization (CDMO) specializing in the production of viral-based cell & gene therapies and advanced therapies.
Our goal is to establish a streamlined, global manufacturing solution for your viral vector product. Our single-use bioreactor platforms, remote monitoring systems, quality driven processes and dedicated staff come together to create an exceptional framework to ensure the product development and manufacturing process keeps pace with the often-accelerated clinical approval pathways to the patient.
Brands: Viral Vector CDMO Service for Lentivirus and AAV vectors
- Cell Line development
- Process Development
- Assay Development and Validation
- GMP Production
- Product Release & Stability Testing